Our Logo
Our Team
- Aviva Lev-Ari, PhD, RN, Director and Founder
- Members of the Board
- Senior Editors
- Experts, Authors, Writers (EAWs)
- Business Development & Private Equity Investment
- Scientific Delegation Members & Patent Holders
- Inventors: Biologics
- Inventors: Medical Devices
- Research Associates
LPBI Group Vision
Work-in-Progress
UPDATED ON 2/21/2016
We are in the Professional Services Sector: e-Scientific Information Creation and Intellectual Property Assets Management:
Subsidiary #1: electronic Scientific Media or Scientific Digital Media – LPBI
- Journal,
- BioMed eSeries,
- Real Time Conference Press,
- Audio-Podcast Series in Medicine
Subsidiary #1, LPBI, our Scientific Digital Media, is been managed to Plan for completion of milestones on 12/2016 – when it will be a candidate for M&A into the electronic Scientific Publishing Industry: Medical Publishers’ Directory – 171 publishing companies that publish Medical books, e-books, magazines. [ Page 1 of 18 ]
http://www.publishersglobal.com/directory/subject/medical-publishers/
Subsidiary #4: We are intermediaries for Commercialization, Licensing, Sales Outright of US Patents, representing Two inventors in Medical Devices
We are in 3D BioPrinting R&D & Drug Discovery R&D:
Subsidiary #3: R&D in 3D BioPrinting – FUNDING needs: $20Million [If VAR considered: $40Million]
Subsidiary #5: R&D in Drug Discovery – FUNDING needs: $20Million
We are in the Financial Transaction Sector
(No Securities Traded):
Subsidiary #2: Deals, Funding and Partnerships
MEDICAL DEVICES
- Representation of Alpha Szensors, Inc. – Programmable sensors nanocarbon tubed for FUNDING – $XMillion for Manufacturing
- Representation of ValveCure – Mitral Valve Repair Probe for M&A – $XMillion Sales
- Representation of Telerescue – individualized portable Defibrilator for aFIB and CHF Patients for FUNDING – $XMillion
PLATFORM – Pharmaceutical KnowledgeBase – Global Relational DB of Oncology Drugs and Clinical Trial – the only one in existence for M&A or Unencumbered Sales of Assets – Quote available
- Representation of New Medicine Inc.
INVENTIONS IN BIOLOGICS
- Representation of BioTerm Therapeutics – Two Drug Devices Colagenease infusion – OBGYN Drug Injection and Syringe apparatus for FUNDING $XMillion each one
- Representation of SBH Sciences, Inc. for FUNDING $X to $2XMillion – Brain Tumor drug
- Representation of Woodlands Pharmaceutics for FUNDING $X to $2XMillion – Liver Fibrosis Drug
Drug Screening Phase to identify IF GDE will represent the following IP:
1. Small Molecules: Inventions of Professor Yedgar, HUJI, Licensable from Yissum, Tech Transfer HUJI
2. Biologics: Inventions of Professor Tirosh, HUJI, Licensable from Yissum, Tech Transfer HUJI – Yossi’s Company
3. Technion Tech Transfer: T-cube – Initiation of Relations by GDE – PENDING
4. Weizmann Institute Tech Transfer: YEDA – Initiation of Relations by GDE – PENDING
Material below that point is OUTDATED
This section is under construction
Our Open Access Online Journal
http://www.pharmaceuticalIntelligence.com
is a scientific, medical and business, multi-expert authoring environment for information syndication in several domains of Life Sciences, Medicine, Pharmaceutical and Healthcare Industries, BioMedicine, Medical Technologies & Devices. Scientific critical interpretations and original articles are written by PhDs, MDs, MD/PhDs, PharmDs, Technical MBAs as Experts, Authors, Writers (EAWs) on an Equity Sharing basis.
Journal Content Descriptors on 2/18/2016
Date | Views to Date |# of articles |NIH Clicks |Nature Clicks
| 02/18/2016 | 886,454 | 4,162 | 2,911 | 1,813 |
Our Competencies
- Deals, Partnerships and Funding for Early Stage Biologics and Medical Devices Start Ups
1. Early Stage Finance for Biologics and Medical Devices Start ups
https://pharmaceuticalintelligence.com/joint-ventures/
2. Medical 3D Printing and BioMaterials Process Control
https://pharmaceuticalintelligence.com/medical-3d-printing/
- Scientific Curations in Medicine and Life Sciences
http://www.pharmaceuticalIntelligence.com
- HealthCare Investor’s Corner
https://pharmaceuticalintelligence.com/options/
- BioMed e-Series of e-Books
https://pharmaceuticalintelligence.com/biomed-e-books/
- Scientific Delegations of US Patent Holders
https://pharmaceuticalintelligence.com/options/scientific-delegation/
- Real Time Coverage of Scientific and Biotech Conferences
MultiMedia Presence
- Twitter.com: http://twitter.com/pharma_BI
@pharma_BI
- FaceBook Page
http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence
- Launchers of a Professional Group on LinkedIn
http://www.linkedin.com/groups?gid=4346921&trk=hb_side_g
- Company Page on LinkedIn
e-Book Titles by LPBI
For more information on Real-Time Conference Coverage and a full listing of Conferences Covered by LPBI please go to:
https://pharmaceuticalintelligence.com/press-coverage/
Leaders in Pharmaceutical Business Intelligence is a Holding Company of Six Ventures:
Venture Overview Updated in New Company Page on LinkedIn: Leaders in Pharmaceutical Business Intelligence – 3/7/2015
e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical– Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com
BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine
https://pharmaceuticalintelligence.com/biomed-e-books/
2013 e-Book on Amazon.com
Perspectives on Nitric Oxide in Disease Mechanisms, on Amazon since 6/2/12013
http://www.amazon.com/dp/B00DINFFYC
2015 e-Book on Amazon.com
1. Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015
http://www.amazon.com/dp/B012BB0ZF0
2. Cancer Biology & Genomics for Disease Diagnosis, on Amazon since 8/11/2015
http://www.amazon.com/dp/B013RVYR2K
3. Genomics Volume One
4. Physiology, Genomics and Pharmaceutical
5. Cardiovascular, Volume Two: Co-Curation, Methodology
6. Cardiovascular Diseases, Volume Three: Etiology, Genetics and Genomics
7. Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine
8. Cancer Volume Two: Immunotherapy, Nanotechnology in drug delivery
2016 we need to FIND Editors for Two e-Books
– Genomics Volume Two on NGS – Dr. Williams and another Editor
– Patient Voice on Invasive Procedures – New Editor
2016, We will continue with
– Aviva will work with Larry on CVD 5: Pharmacology-Therapy,
– With Adam and Dr. Pearlman, on CVD 6: Cardiac Surgery and Interventional
– With Adam and Dr. Pearlman, on CVD 7: CV Imaging
– Dr. Pearlman alone:
Three CVD Hardcopy Volumes, 1-Etiology, 2-Diagnostics, 3-Therapies
- VENTURE #3:
International Scientific Delegations https://pharmaceuticalintelligence.com/scientific-delegation
- VENTURE #4:
https://pharmaceuticalintelligence.com/joint-ventures/
Business Development Plan for LPBI
– investors in Shanghai, China for funding Biologics and Medical Devices (Wilferd van Opstal)
– investors in Switzerland to find an e-Publisher to buy the Journal and the e-Books (Gerard Loiseau)
– a 3D Printing Swiss company – RegenHU — to establish Partnerships with MIT, GE, J&J [Adam on P&G]
– Adam drafts Patents with Bill Zurn on implantable Cardiovascular device – I am discussing Zurn’s IP with investors in Shanghai and NYC
– I work with investors in NYC (Nicholas Hall, Private Wealth Management, Maxim Group LLC) on Deals, Funding and Partnerships
- VENTURE #5:
IP Invented HERE!
- VENTURE # 6:
Real Time PRESS Coverage International Biotech Conferences
https://pharmaceuticalintelligence.com/press-coverage/
Funding, Deals & Partnerships
- Corporate Clients for our Services
- Funding Cardiovascular Medical Devices Development
- Funding Biologics Development
- Funding Diagnostics
- Funding Partnerships in IP Development
- M&A and Exit
- Targeting Penetration in New Markets for High Technology Products
- Management of Engineering Design of Prototypes Outsourcing
Our Growth Needs: Leaders in Pharmaceutical Business Intelligence
Our Business Portfolio
VENTURE #1:
e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical
-
Open Access Online Scientific Journal
11/19/2014 – PRESS RELEASE — Over 500,000 Unique Site Visits reached by PharmaceuticalIntelligence.com Reported today by Leaders in Pharmaceutical Business Intelligence (LPBI)
http://pharmaceuticalintelligence.com
-
Scoop.it!.com
- http://www.scoop.it/t/cardiotoxicity
- http://www.scoop.it/t/cardiovascular-and-vascular-imaging
- http://www.scoop.it/t/cardiovascular-disease-pharmaco-therapy
VENTURE #2:
1. BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine
https://pharmaceuticalintelligence.com/biomed-e-books/
- Series A: e-Books on Cardiovascular Diseases
- Series B: Frontiers in Genomics Research
- Series C: e-Books on Cancer & Oncology
- Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases
- Series E: Titles in the Strategic Plan for 2014-2015
2. on Amazon’s Kindle e-Books List since 6/2013
3. Plans for Volume 1,2,3 – Hardcover
- Cardiovascular Diseases: Causes, Risks and Management – Volume 1,2,3 – Hardcover
4. Schedule Plan for e-Publishing on Amazon.com
- Publishing on Amazon Kindle – SIX Volumes in 2015:
1. Metabolomics, Volume One
2. Genomics, Volume One
3. Cancer Volume One
4. Cardiovascular – Volume 2
5. Cardiovascular – Volume 3
6. Cardiovascular – Volume 4
- Publishing on Amazon Kindle – Four Volumes in 2016:
1. Physiology, PharmacoTherapy and Genomics: The Patient-centered Medicine Perspective
2. Cancer, Volume Two
3. Cardiovascular – Volume 5
4. Cardiovascular – Volume 6
VENTURE #3:
International Scientific Delegations https://pharmaceuticalintelligence.com/scientific-delegation/
- Shanghai, May 2015
- Barcelona, Spain, November 2015
- Amsterdam, May 2016
- Geneva, November 2016
VENTURE #4:
Funding, Deals & Partnerships
https://pharmaceuticalintelligence.com/joint-ventures/
- Corporate Clients for our Services
- Funding Cardiovascular Medical Devices Development
- Funding Biologics Development
- Funding Diagnostics
- Funding Partnerships in IP Development
- M&A and Exit
- Targeting Penetration in New Markets for High Technology Products
- Management of Engineering Design of Prototypes Outsourcing
VENTURE #5:
IP Invented HERE!
1. Development of a NEW Nitric Oxide monitor to Alpha Szenszor Inc. sensor portfolio. A concept for a low cost POC e-nose, capable of real time ppb detection of Cancer The Cancer Team at Leaders in Pharmaceutical Business Intelligence under the leadership of Dr. Williams 2. Development of a NEW Nitric Oxide monitor to Alpha Szenszor Inc. sensor portfolio. A concept for Inhaled Nitric Oxide for the Adult HomeCare Market – IP by Dr. Pearlman and Dr. A. Lev-Ari
a. iknow iNO is i-kNOw – Inhaled Nitric Oxide for the HomeCare Market https://pharmaceuticalintelligence.com/2013/10/16/iknow-ino-is-i-know-inhaled-nitric-oxide-for-the-homecare-market/
b. electronic Book on Nitric Oxide by Nitric Oxide Team @ Leaders in Pharmaceutical Business Intelligence (LPBI)
Perspectives on Nitric Oxide in Disease Mechanisms
http://www.amazon.com/dp/B00DINFFYC
c. The rationale and use of inhaled NO in Pulmonary Artery Hypertension and Right Sided Heart Failure Larry H. Bernstein 8/20/2012
d. Inhaled Nitric Oxide in Adults: Clinical Trials and Meta Analysis Studies – Recent Findings
Aviva Lev-Ari, PhD, RN, 6/2/2013
Aviva Lev-Ari, PhD, RN, 6/3/2013
3. Cancer Genomics for NEW product development in diagnosis and treatment of Cancer Patients using sensory technology with applications for Radiation Therapy – The Cancer Team at Leaders in Pharmaceutical Business Intelligence under leadership of Dr. Larry H Bernstein, MD, FCAP
4. Developing Mitral Valve Disease: MRI Methods and Devices for Percutaneous Mitral Valve Replacement and Mitral Valve Repair Augmentation of Patented Technology using RF – Dr. Pearlman’s IP Non-Hardware Mitral Annuloplasty – Dr. Justin D. Pearlman
5. Novel Technology using MRI for Vascular Lesions, Tumors, Hyperactive Glands and non-Surgical Cosmetic Reconstruction – Dr. Pearlman’s IP
http://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/httppharmaceuticalintelligence-combiomed-e-bookscardiovascular-diseases-causes-risks-and-management/cvd-business-affairs/mitral-valve-disease-mri-methods-and-devices/
VENTURE # 6:
PRESS Coverage of Conferences
https://pharmaceuticalintelligence.com/press-coverage/
2012pharmaceutical
Aashir Awan, Phd
Alan F. Kaul, PharmD., MS, MBA, FCCP
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
evelinacohn
Gail S Thornton
Irina Robu
jdpmd
jukkakarjalainen
kellyperlman
Ed Kislauskis
larryhbern
lmulligan13gmailcom
marzankhan
megbaker58
pkandala
Rosalind Codrington, PhD
ritusaxena
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
[…] Vision […]
[…] Vision […]
Dear Dr. Lev-Ari,
Thank you so much for your invitation. I will be honoured to join your team of experts, authors, writers.
With friendly regards
Lilia
You are welcome, you can suggest to me what are the activities you wigs to get involved with, any Venture above, can use your talent.